Breakthrough Study led by Edgar Engleman Identifies Key Immune Switch That Could Revolutionize Treatments for Autoimmunity and other diseases

Researchers discover how erythropoietin (EPO) signaling in dendritic cells (cDC1s) regulates immune tolerance, offering new pathways for treating diseases like diabetes and other autoimmune conditions.


Next
Next

Type 1 Diabetes Cured in Groundbreaking Study with mice by SDRC investigators